Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will publish its first quarter 2026 financial ...
Barchart on MSN
Cathie Wood is buying up Alamar Biosciences stock after its IPO. Should you snag proteomics-focused ALMR too?
Some IPOs fade into the background after their first week of trading. Alamar Biosciences (ALMR) is not one of them, though.
About This EventAlamar Biosciences (Nasdaq: ALMR), a company focussed on enabling the earliest detection of disease, visits ...
Alamar Biosciences (ALMR) stock surges ~40% after the commercial-stage proteomics company priced its upsized IPO at $17 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results